SINOVAC BIOTECH (HONG KONG) LIMITED Company Profile,SINOVAC BIOTECH (HONG KONG) LIMITED Essential Information

Company Profile

Our Company Our Business

Year Established : 2001

Total Assets(USD) : choose not to disclose

Total Number of Staff : 20 to 29

Main Competitive Advantages : Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production capacity,Buyers Specifications Accepted,Small Orders Accepted,Reputation

Other Competitive Advantages : Export to many countries and have rich experience in Registration and international sales. Barrier free communication. Strict control of quality.

Patents and Copyrights : Inlive Healive Bilive Anflu Panflu PANFLU.1 and over 50 patent in production process

Send Inquiry

Sinovac Biotech (Hong Kong) Ltd. holds 73.09% of the shares of of Sinovac Biotech Co., Ltd. which is a China-based biopharmaceutical company that aiming to provide Chinese children with international quality vaccine and provide Children in the world with vaccines made in China.
To achieve these objectives, Sinovac focuses research, development, manufacture and commercialization of vaccines for infectious diseases with significant unmet medical need.
Sinovac also provides services for diseases control and prevention, collaborating with the Chinese governments at the national, state and county levels.
Main products are Haelive，Inlive，Anful ect. The products have been sold to over 70 countries and regions in the world.

Company Profile of SINOVAC BIOTECH (HONG KONG) LIMITED

Company Profile